^
Association details:
Biomarker:No biomarker
Cancer:Neuroendocrine Tumor
Regimen:EP (cisplatin + etoposide IV)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Bronchopulmonary/Thymus Neuroendocrine Tumors: Useful in Certain Circumstances...Cisplatin + etoposide